Skip to content

Talphera, Inc. TLPH Free cash flow

Discontinued — last reported Q4 '24

Free cash flow at other companies

AMP
Amphastar PharmaceuticalsAMPH
$38.33M+57.2%
PTH
Pelthos Therapeutics Inc.PTHS
-$13.32M-2,008%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$6.11M+173%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$48.46M+289%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
-$198M-18.6%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS

Other financials

Income statement

See full
Revenue--100%
Gross profit-$1.9M-52.7%
Operating income-$3.9M-35.4%
Net income-$2.6M+1.4%
EPS (diluted)-$0.10+37.5%

Balance sheet

See full
Cash & equivalents$3.8M-29.0%
Total debt$3.4M-79.7%
Total equity$18.5M+230%
Total assets$30.2M+101%

Cash flow

See full
Operating cash flow-$3.4M+2.0%
CapEx-

Valuation

See full
Market cap$53.46M+493%
P/S53,456.6×+53,123×

Profitability

See full
Gross margin-127.7%-136pp
Operating margin-1,451,600%-1,507,145pp
Net margin-1,425,300%-1,471,200pp
FCF margin-5,116.7%-6,779pp

Returns & leverage

See full
Return on equity-118.4%+15.4pp
Debt / equity0.2×
Current ratio5.3×+2.2×

Where this comes from

Calculated from Talphera, Inc.’s reported figures.

The official record: Talphera, Inc.’s 10-K, filed March 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Talphera, Inc.'s free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Talphera, Inc.'s free cash flow?
Talphera, Inc. (TLPH) reported free cash flow of -$2.25M in Q4 2024.
How has Talphera, Inc.'s free cash flow changed year-over-year?
Talphera, Inc.'s free cash flow increased by 42.9% year-over-year, from -$3.95M to -$2.25M.
What is the long-term trend for Talphera, Inc.'s free cash flow?
Over 3 years (2021 to 2024), Talphera, Inc.'s free cash flow has grown at a -26.4% compound annual growth rate (CAGR), from -$31.83M to -$12.68M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.